Ackman, in email, says supports Valeant CEO Pearson
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Tech selloff weighs down Wall Street as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Goldman Sachs to acquire real estate company LCN for up to $410M
- BofA raises hyperscaler AI capex outlook to $3.6tn through 2028
Valeant (VRX) Price Target Cut to $195 at Guggenheim; Thesis Intact
November 6, 2015 6:29 AM ESTGuggenheim analyst Louise Chen lowered her price target on Valeant Pharmaceuticals (NYSE: VRX) to $195.00 (from $300.00) but maintained a Buy rating saying the investment thesis remains intact.
Chen commented, "We are lowering our PT for VRX to $195 from $300. The decrease in our PT is... More
Is a 'Fire Sale' in Store for Valeant Pharma (VRX)?
November 5, 2015 3:42 PM ESTWith all hope lost, speculators wonder if a fire sale may be the last resort to stop the bleeding in Valeant Pharma (NYSE: VRX) shares.
Trades are keenly focusing on the last line in Bill Ackman's letter supporting Valeant Pharma... More
Worst Case Valeant (VRX) is a Buy - Mizuho
November 5, 2015 3:13 PM ESTMizuho Securities analyst Irina Koffler said worse case analysis and Valeant Pharmaceuticals (NYSE: VRX) is a Buy. The firm reiterated a Buy rating and $155 price target.
The stock is no longer trading on fundamentals in our view. We look at a liquidation valuation in the extreme case that management is ousted and the business is put up for sale under distressed conditions. We conclude shares are undervalued and reiterate our BUY rating
Key points:
We try to remain rational and reiterate our BUY rating: We understand the... More